ÂÜÀòÂÒÂ×

Quentin Vicentini is an experienced researcher with a focus on chemistry and drug discovery. Currently serving as an Early Stage Researcher and PhD Student at AstraZeneca since September 2021, Quentin's previous roles include co-founding Resolving Pharma, where the mission is to inform investors and scientists about innovative pharmaceutical technologies. Additional experience includes a Marie Skłodowska-Curie fellowship at DNA-Robotics, where Quentin specialized in oligonucleotide synthesis and CRISPR-Cas9 design. Early career experiences range from internships in medicinal chemistry at AstraZeneca to roles in clinical research and compound synthesis at organizations such as Bayer and Inserm. Quentin holds a Doctor of Philosophy in Chemistry from Karolinska Institutet, along with a Doctor of Pharmacy from the University of Lille 1 Sciences and Technology and Master's degrees in Modern Drug Discovery and Drug Design.